Medical comms - Press Releases

Date	Title	Company
14-Jul-2022	Grünenthal acquires testosterone treatment Nebido™ from Bayer	Bayer
13-Jul-2022	PharmiWeb.Jobs Welcomes Excelya	PharmiWeb.Jobs
07-Jun-2022	EVERSANA™ Unveils EVERSANA INTOUCH, a Next-Generation Agency Network Delivering Award-Winning Creative, Digital, and Global Market Access Solutions for Life Sciences	EVERSANA™
02-Jun-2022	Cardiac Rhythm Management Devices Market is estimated to be US$ 6.63 billion by 2030 with a CAGR of 11.5% during the forecast period	Prophecy Market Insights
23-May-2022	HEALTH POLICY & CHANGE COMMUNICATIONS EXPERTS BOLSTER THE DIFFERENCE COLLECTIVE’S OFFERING TO HEALTHCARE CLIENTS	The Difference Collective
20-May-2022	SAE Media Group Announces the date for 2nd Annual Aseptic Processing Conference	SAE Media Group
19-May-2022	RetInSight Fluid Monitor provides next evolutionary step in monitoring of neovascular age-related macular degeneration	RetInSight
12-May-2022	This move is important to you. To support you to get that job, PharmiWeb.Jobs are delighted to announce they’ve partnered with CareerJay	CareerJay, PharmiWeb
10-May-2022	Faculty Opinions makes the insights and article recommendations from its global network of life sciences and medical experts free-to-access	Faculty Opinions
03-May-2022	Europe’s first dual orexin receptor antagonist – QUVIVIQ (daridorexant) – granted approval to improve both nighttime symptoms and daytime functioning in adults with chronic insomnia disorder	Idorsia
21-Apr-2022	Arne W. Dirks to take over as new CEO of PARI Medical Holding GmbH	PARI
12-Apr-2022	Global Smoke Evacuation Systems Market, By Product, Share, Outlook, Forecast 2022-2028	Blueweave Consulting
06-Apr-2022	FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA	SMi Group
05-Apr-2022	Envision Pharma Group expands capabilities with specialist behavioral science offering Envision the Change	Envision Pharma Group
05-Apr-2022	AXON hires a Global Healthcare Insights and Strategy Lead	AXON
31-Mar-2022	Novartis UK response to NICE Appraisal Consultation Document (ACD) for Piqray (alpelisib) for advanced breast cancer patients	Novartis
30-Mar-2022	New analysis shows that Kesimpta®▼ (ofatumumab)-treated adults with relapsing remitting multiple sclerosis (RRMS) are not at increased risk of severe COVID-19 infections	Novartis
25-Mar-2022	ICR welcomes FDA approval of ‘search and destroy’ treatment	The Institute of Cancer Research
25-Mar-2022	Tiziana Announces Initiation of Phase 1b Clinical Trial in Crohn’s Disease Patients to Evaluate Oral Capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody	Tiziana Life Sciences Ltd
25-Mar-2022	XFret Wins the 2021 Sustainability Award – Startup/Small Business Category	TIACA